A novel dual MEK/PDK1 inhibitor 9za retards the cell cycle at G0/G1 phase and induces mitochondrial apoptosis in non-small cell lung cancer cells
Background A novel dual MEK/PDK1 inhibitor named 9za has been synthesized by our research team. Preliminary study showed that 9za possessed potent cytotoxicity and proapoptosis in non-small cell lung cancer (NSCLC) cells. Nevertheless, the precise underlying mechanism is vague. Methods In this work,...
Main Authors: | Rangru Liu, Zutao Yu, Zhuo Chen, Danqi Liu, Fengying Huang, Qianbin Li, Gaoyun Hu, Xinan Yi, Xi Li, Honghao Zhou, Zhaoqian Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-10-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/9981.pdf |
Similar Items
-
A Novel PDK1/MEK Dual Inhibitor Induces Cytoprotective Autophagy via the PDK1/Akt Signaling Pathway in Non-Small Cell Lung Cancer
by: Rangru Liu, et al.
Published: (2023-02-01) -
The kinase PDK1 is critical for promoting T follicular helper cell differentiation
by: Zhen Sun, et al.
Published: (2021-02-01) -
PDK1- and PDK2-mediated metabolic reprogramming contributes to the TGFβ1-promoted stem-like properties in head and neck cancer
by: Wan-Hsuan Sun, et al.
Published: (2022-12-01) -
Targeting PDK1 for Chemosensitization of Cancer Cells
by: Aikaterini Emmanouilidi, et al.
Published: (2017-10-01) -
Phosphorylation of LKB1 by PDK1 Inhibits Cell Proliferation and Organ Growth by Decreased Activation of AMPK
by: Sarah Borkowsky, et al.
Published: (2023-03-01)